GNAS and pseudohypoparathyroidism type 1A: Multiple inactivating mutations have been described in humans that are associated with AHO [12], [13], [14] and POH [7], [15], [16]; all result in the reduction of the Gsα protein, resulting in loss of GDP and GTP binding.